<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font18 { font-size : 18; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font29 { font-size : 29; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font29">and </span>
   <span class="font18">for </span>
   <span class="font16">were </span>
   <span class="font16">influenza </span>
   <span class="font15">was </span>
   <span class="font15">with </span>
   <span class="font14">mice </span>
   <span class="font14">AAV </span>
   <span class="font14">from </span>
   <span class="font14">Ra-B </span>
   <span class="font13">that </span>
   <span class="font13">:–. </span>
   <span class="font12">against </span>
   <span class="font12">mouse </span>
   <span class="font12">(Figure </span>
   <span class="font12">virus </span>
   <span class="font12">which </span>
   <span class="font12">not </span>
   <span class="font12">(). </span>
   <span class="font12">antibody </span>
   <span class="font12">given </span>
   <span class="font12">have </span>
   <span class="font11">The </span>
   <span class="font11">{background </span>
   <span class="font11">days </span>
   <span class="font11">antibodies </span>
   <span class="font11">challenge </span>
   <span class="font11">expression </span>
   <span class="font11">single </span>
   <span class="font11">using </span>
   <span class="font11">protection </span>
   <span class="font11">are </span>
   <span class="font11">delivery </span>
   <span class="font11">domain </span>
   <span class="font11">gene </span>
   <span class="font11">any </span>
   <span class="font11">neutralizing </span>
   <span class="font11">fusion </span>
   <span class="font11">margin </span>
   <span class="font11">shown </span>
   <span class="font11">(Sigma </span>
   <span class="font11">Ra-B, </span>
   <span class="font11">immune </span>
   <span class="font11">serum </span>
   <span class="font11">{border-style </span>
   <span class="font11">levels </span>
   <span class="font11">nanobody </span>
   <span class="font11">study </span>
   <span class="font11">this </span>
   <span class="font11">binding </span>
   <span class="font11">px;} </span>
   <span class="font11">sera </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">Mice </span>
   <span class="font11">PBS </span>
   <span class="font11">been </span>
   <span class="font11">then </span>
   <span class="font11">viral </span>
   <span class="font11">after </span>
   <span class="font11">cells </span>
   <span class="font11">via </span>
   <span class="font11">vivo </span>
   <span class="font11">(v/v) </span>
   <span class="font11">infection </span>
   <span class="font11">neutralization </span>
   <span class="font11">through </span>
   <span class="font10">This </span>
   <span class="font10">also </span>
   <span class="font10">efficacy </span>
   <span class="font10">has </span>
   <span class="font10">transgene </span>
   <span class="font10">vector </span>
   <span class="font10">ADCC </span>
   <span class="font10">Ra-B-Fc </span>
   <span class="font10">can </span>
   <span class="font10">did </span>
   <span class="font10">different </span>
   <span class="font10">encoding </span>
   <span class="font10">expressing </span>
   <span class="font10">groups </span>
   <span class="font10">human </span>
   <span class="font10">vectors </span>
   <span class="font10">μg/mL </span>
   <span class="font10">Ra-B-mIgGa </span>
   <span class="font10">Supplementary </span>
   <span class="font10">activity </span>
   <span class="font10">effector </span>
   <span class="font10">group </span>
   <span class="font10">into </span>
   <span class="font10">lung </span>
   <span class="font10">nanobody-Fc </span>
   <span class="font10">pandemic </span>
   <span class="font10">stem </span>
   <span class="font10">Ra-B-mIgG, </span>
   <span class="font10">control </span>
   <span class="font10">culled </span>
   <span class="font10">injection </span>
   <span class="font10">vitro </span>
   <span class="font10">CA/ </span>
   <span class="font10">For </span>
   <span class="font10">HAI </span>
   <span class="font10">Ra-B-mIgGa, </span>
   <span class="font10">cAb-mIgGa </span>
   <span class="font10">complete </span>
   <span class="font10">previously </span>
   <span class="font10">provide </span>
   <span class="font10">showed </span>
   <span class="font10">tested </span>
   <span class="font10">would </span>
   <span class="font10">D). </span>
   <span class="font10">Immunol. </span>
   <span class="font10">Influenza </span>
   <span class="font10">Med. </span>
   <span class="font10">both </span>
   <span class="font10">dilution </span>
   <span class="font10">highly </span>
   <span class="font10">lethal </span>
   <span class="font10">loss </span>
   <span class="font10">low </span>
   <span class="font10">mAbs </span>
   <span class="font10">monoclonal </span>
   <span class="font10">monovalent </span>
   <span class="font10">per </span>
   <span class="font10">prophylactic </span>
   <span class="font10">received </span>
   <span class="font10">specific </span>
   <span class="font10">than </span>
   <span class="font10">their </span>
   <span class="font10">weight </span>
   <span class="font10">Ra-B-mIgG </span>
   <span class="font10">Table </span>
   <span class="font10">able </span>
   <span class="font10">conserved </span>
   <span class="font10">cross-subtype </span>
   <span class="font10">described </span>
   <span class="font10">expressed </span>
   <span class="font10">fusions </span>
   <span class="font10">high </span>
   <span class="font10">intramuscular </span>
   <span class="font10">mediated </span>
   <span class="font10">new </span>
   <span class="font10">post-challenge </span>
   <span class="font10">potent </span>
   <span class="font10">potential </span>
   <span class="font10">px; </span>
   <span class="font10">response </span>
   <span class="font10">see </span>
   <span class="font10">show </span>
   <span class="font10">symptoms </span>
   <span class="font10">these </span>
   <span class="font10">used </span>
   <span class="font10">{font-family </span>
   <span class="font10">(data </span>
   <span class="font10">A(HN) </span>
   <span class="font10">All </span>
   <span class="font10">IgG </span>
   <span class="font10">IgGa </span>
   <span class="font10">MLD </span>
   <span class="font10">added </span>
   <span class="font10">addition, </span>
   <span class="font10">additional </span>
   <span class="font10">adeno-associated </span>
   <span class="font10">all </span>
   <span class="font10">bind </span>
   <span class="font10">broadly </span>
   <span class="font10">cAb-mIgGa, </span>
   <span class="font10">clinical </span>
   <span class="font10">concentration </span>
   <span class="font10">detected </span>
   <span class="font10">each </span>
   <span class="font10">font-size </span>
   <span class="font10">interactions </span>
   <span class="font10">level </span>
   <span class="font10">may </span>
   <span class="font10">measured </span>
   <span class="font10">nanobodies </span>
   <span class="font10">seen </span>
   <span class="font10">shown). </span>
   <span class="font10">subtypes </span>
   <span class="font10">system </span>
   <span class="font10">therapy </span>
   <span class="font10">they </span>
   <span class="font10">weeks </span>
   <span class="font10">(HN) </span>
   <span class="font10">A), </span>
   <span class="font10">BALB/c </span>
   <span class="font10">Biological </span>
   <span class="font10">Division </span>
   <span class="font10">FcγR </span>
   <span class="font10">Figure </span>
   <span class="font10">Health </span>
   <span class="font10">Institute </span>
   <span class="font10">Our </span>
   <span class="font10">Plates </span>
   <span class="font10">These </span>
   <span class="font10">avian </span>
   <span class="font10">circulation </span>
   <span class="font10">compared </span>
   <span class="font10">could </span>
   <span class="font10">dependent </span>
   <span class="font10">development </span>
   <span class="font10">dose </span>
   <span class="font10">double; </span>
   <span class="font10">due </span>
   <span class="font10">either </span>
   <span class="font10">end </span>
   <span class="font10">format </span>
   <span class="font10">genome </span>
   <span class="font10">hemagglutinin </span>
   <span class="font10">higher </span>
   <span class="font10">infiltration </span>
   <span class="font10">intranasal </span>
   <span class="font10">its </span>
   <span class="font10">lungs </span>
   <span class="font10">more </span>
   <span class="font10">muscle </span>
   <span class="font10">natural </span>
   <span class="font10">need </span>
   <span class="font10">only </span>
   <span class="font10">other </span>
   <span class="font10">potency </span>
   <span class="font10">rAAV </span>
   <span class="font10">ranging </span>
   <span class="font10">studies </span>
   <span class="font10">thickening </span>
   <span class="font10">those </span>
   <span class="font10">transgenes </span>
   <span class="font10">two </span>
   <span class="font10">under </span>
   <span class="font10">very </span>
   <span class="font10">&amp;lt; </span>
   <span class="font10">(A) </span>
   <span class="font10">./fimmu.. </span>
   <span class="font10">:e. </span>
   <span class="font10">A(HN), </span>
   <span class="font10">A/Vietnam// </span>
   <span class="font10">ELISA </span>
   <span class="font10">Each </span>
   <span class="font10">FIGURE </span>
   <span class="font10">Gene </span>
   <span class="font10">HN, </span>
   <span class="font10">However, </span>
   <span class="font10">Kingdom[], </span>
   <span class="font10">National </span>
   <span class="font10">Opin </span>
   <span class="font10">Standards </span>
   <span class="font10">Ther. </span>
   <span class="font10">University </span>
   <span class="font10">affinity </span>
   <span class="font10">anti-influenza </span>
   <span class="font10">antigen </span>
   <span class="font10">article </span>
   <span class="font10">being </span>
   <span class="font10">between </span>
   <span class="font10">blood </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">broad </span>
   <span class="font10">bronchioles </span>
   <span class="font10">constructs </span>
   <span class="font10">contrast, </span>
   <span class="font10">cross-neutralizing </span>
   <span class="font10">delivered </span>
   <span class="font10">delivery. </span>
   <span class="font10">determine </span>
   <span class="font10">determined </span>
   <span class="font10">dilutions </span>
   <span class="font10">effective </span>
   <span class="font10">epitope </span>
   <span class="font10">evaluate </span>
   <span class="font10">fragment </span>
   <span class="font10">half-life </span>
   <span class="font10">immunoprophylaxis </span>
   <span class="font10">incubated </span>
   <span class="font10">independent </span>
   <span class="font10">inflammation </span>
   <span class="font10">intranasally </span>
   <span class="font10">line </span>
   <span class="font10">long </span>
   <span class="font10">lower </span>
   <span class="font10">made </span>
   <span class="font10">method </span>
   <span class="font10">model </span>
   <span class="font10">negative </span>
   <span class="font10">our </span>
   <span class="font10">over </span>
   <span class="font10">post-AAV </span>
   <span class="font10">present </span>
   <span class="font10">receiving </span>
   <span class="font10">reported </span>
   <span class="font10">represent </span>
   <span class="font10">samples </span>
   <span class="font10">serotype </span>
   <span class="font10">solid; </span>
   <span class="font10">some </span>
   <span class="font10">strain </span>
   <span class="font10">structure </span>
   <span class="font10">suggests </span>
   <span class="font10">systemic </span>
   <span class="font10">taken </span>
   <span class="font10">terminal </span>
   <span class="font10">therapeutic </span>
   <span class="font10">titers </span>
   <span class="font10">transfer </span>
   <span class="font10">well </span>
   <span class="font10">whereas </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(B) </span>
   <span class="font10">(Figures </span>
   <span class="font10">(Supplementary </span>
   <span class="font10">-days </span>
   <span class="font10">.). </span>
   <span class="font10">./.. </span>
   <span class="font10">./journal.pone. </span>
   <span class="font10">A). </span>
   <span class="font10">After </span>
   <span class="font10">Assay </span>
   <span class="font10">B). </span>
   <span class="font10">CA/. </span>
   <span class="font10">Control </span>
   <span class="font10">Delivery </span>
   <span class="font10">Engl </span>
   <span class="font10">Expression </span>
   <span class="font10">From </span>
   <span class="font10">Mouse </span>
   <span class="font10">NIBRG-ma </span>
   <span class="font10">NIBRG-ma. </span>
   <span class="font10">Nanobodies </span>
   <span class="font10">One. </span>
   <span class="font10">Scientific </span>
   <span class="font10">Viral </span>
   <span class="font10">World </span>
   <span class="font10">ability </span>
   <span class="font10">above </span>
   <span class="font10">absence </span>
   <span class="font10">activity. </span>
   <span class="font10">administration </span>
   <span class="font10">air </span>
   <span class="font10">animal </span>
   <span class="font10">approach </span>
   <span class="font10">arm </span>
   <span class="font10">bold </span>
   <span class="font10">capable </span>
   <span class="font10">carried </span>
   <span class="font10">chains </span>
   <span class="font10">challenge, </span>
   <span class="font10">concentrations </span>
   <span class="font10">courier; </span>
   <span class="font10">data </span>
   <span class="font10">day </span>
   <span class="font10">diluted </span>
   <span class="font10">doses </span>
   <span class="font10">duration </span>
   <span class="font10">em; </span>
   <span class="font10">enhance </span>
   <span class="font10">epitopes </span>
   <span class="font10">extended </span>
   <span class="font10">extension </span>
   <span class="font10">four </span>
   <span class="font10">functions </span>
   <span class="font10">further </span>
   <span class="font10">hemagglutination </span>
   <span class="font10">highest </span>
   <span class="font10">histological </span>
   <span class="font10">host </span>
   <span class="font10">immunotherapy </span>
   <span class="font10">individual </span>
   <span class="font10">induced </span>
   <span class="font10">injection. </span>
   <span class="font10">isotypes </span>
   <span class="font10">key </span>
   <span class="font10">maximum </span>
   <span class="font10">mechanism </span>
   <span class="font10">mechanisms </span>
   <span class="font10">membrane </span>
   <span class="font10">months </span>
   <span class="font10">neutralize </span>
   <span class="font10">observed </span>
   <span class="font10">obtained </span>
   <span class="font10">overnight </span>
   <span class="font10">passive </span>
   <span class="font10">patient </span>
   <span class="font10">perivascular </span>
   <span class="font10">point </span>
   <span class="font10">post </span>
   <span class="font10">pre-challenge </span>
   <span class="font10">production </span>
   <span class="font10">protect </span>
   <span class="font10">protective </span>
   <span class="font10">protein </span>
   <span class="font10">proteins </span>
   <span class="font10">pseudotypes </span>
   <span class="font10">pt;} </span>
   <span class="font10">reactivity </span>
   <span class="font10">receptor </span>
   <span class="font10">recombinant </span>
   <span class="font10">reformatted </span>
   <span class="font10">relative </span>
   <span class="font10">represents </span>
   <span class="font10">required </span>
   <span class="font10">significant </span>
   <span class="font10">stable </span>
   <span class="font10">standard </span>
   <span class="font10">study, </span>
   <span class="font10">such </span>
   <span class="font10">sufficient </span>
   <span class="font10">survived </span>
   <span class="font10">sustained </span>
   <span class="font10">test </span>
   <span class="font10">there </span>
   <span class="font10">time </span>
   <span class="font10">titer </span>
   <span class="font10">triple </span>
   <span class="font10">two-fold </span>
   <span class="font10">until </span>
   <span class="font10">use </span>
   <span class="font10">vaccine </span>
   <span class="font10">vaccines </span>
   <span class="font10">values </span>
   <span class="font10">without </span>
  </p>
 </body>
</html>
